Democratic Republic of Congo has declared an end to the latest ebola outbreak that infected over twelve (12) people in the eastern province of North Kivu and killed six of them.
The aid group, Medecins Sans Frontieres (MSF), reveals that the outbreak was contained using Merck’s (MRK.N) Ebola vaccine, which was given to more than 1,600 of the patients’ contacts and contacts of contacts.
The cases were genetically linked to the 2018-20 Ebola epidemic that reported killed more than 2,200 people, the second-highest toll recorded in the disease’s history.
The latest flare-up emerged on Feb. 3 in the city of Butembo with the death of a woman whose husband had contracted the virus in the previous outbreak.
The announcement was made on Monday by the country’s health minister Jean-Jacques Mbungani.
The health minister said in a statement “I am pleased to solemnly declare the end of the 12th epidemic of Ebola virus disease in North Kivu Province.”
“Despite the security context and the COVID-19 pandemic, the rapidity and efficiency of the response put in place by the government and its partners made it possible to defeat this pandemic in less than three months,” he added.
Meanwhile, World Health Organization(WHO) said in a statement that the response to the disease was often hampered by insecurity caused by armed groups and social unrest which limited the movement of health workers.
According to research, the virus can remain in certain body fluids, including semen of a patient who has recovered from the disease, even if they no longer have symptoms of severe illness.